Diagnóstico dermatológico del melanoma. Estadificación. Seguimiento > 29 LECTURAS RECOMENDADAS Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer International Publishing; 2017. p. 1024. Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol 2014;170(1):20-30. Mangas C, Paradelo C, Puig S, et al. Valoración inicial, diagnóstico, estadificación, tratamiento y seguimiento de los pacientes con melanoma maligno primario de la piel. Documento de consenso de la Xarxa de Centres de Melanoma de Catalunya i Balears. Actas Dermosifiliogr 2010;101(2):129-42. National Comprehensive Cancer Network (NCCN). Melanoma (Version 1.2017). Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/ physician_gls/pdf/melanoma.pdf Watts CG, Dieng M, Morton RL, et al. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. Br J Dermatol 2015;172(1):33-47. BIBLIOGRAFÍA 1. Mangas C, Paradelo C, Puig S, et al. Valoración inicial, diagnóstico, estadificación, tratamiento y seguimiento de los pacientes con melanoma maligno primario de la piel. Documento de consenso de la Xarxa de Centres de Melanoma de Catalunya i Balears. Actas Dermosifiliogr 2010;101(2):129-42. 2. Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol 2014;170(1):20-30. 3. StratigosAJ, ForseaAM, van der Leest RJ, et al. Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future. Br J Dermatol 2012;167(Suppl 2):99-104. 4. Watts CG, Dieng M, Morton RL, et al. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. Br J Dermatol 2015;172(1):33-47. 5. Dummer R, Hauschild A, Lindenblatt N, et al.; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26(Suppl 5):v126-32. 6. Fink C, Haenssle HA. Non-invasive tools for the diagnosis of cutaneous melanoma. Skin Res Technol 2016;22. 7. Puig S, Malvehy J. Monitoring patients with multiple nevi. Dermatol Clin 2013;31(4):565-77. 8. Salerni G, Carrera C, Lovatto L, et al. Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol 2012;67(1):e17-27. 9. National Comprehensive Cancer Network (NCCN). Melanoma (Version 4.2020). Available from: https://www.nccn. org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf 10. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer International Publishing; 2017. p. 1024. 11. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;20;27(36):6199-206. 12. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;13;370(7):599-609. 13. Marsden JR, Newton-Bishop JA, Burrows L, et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010;163(2):238-56. 14. Romano E, Scordo M, Dusza SW, et al. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 2010;28:3042-7. 15. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 2005;6:608-21.
RkJQdWJsaXNoZXIy OTI4NTYw